• Combination with vorinostat enhances the antitumor activity of cisplatin in castration-resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH.
• Chang T, Lian Z, Ma S, Liang Z, Ma X, Wen X, Wang Y, Liu R.
• Prostate. 2022 Dec 28. doi: 10.1002/pros.24479. Epub ahead of print.

• PMID: 36576015
• PubMed abstract
• Source abstract